![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 45/06 | |
A61K 31/52 | |||
A61K 31/519 | |||
C07K 16/28 | |||
A61K 39/395 |
(11) | Number of the document | 3003309 |
(13) | Kind of document | T |
(96) | European patent application number | 14804451.4 |
Date of filing the European patent application | 2014-05-30 | |
(97) | Date of publication of the European application | 2016-04-13 |
(45) | Date of publication and mention of the grant of the patent | 2020-09-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/040337 |
Date | 2014-05-30 |
(87) | Number | WO 2014/194254 |
Date | 2014-12-04 |
(30) | Number | Date | Country code |
201361829168 P | 2013-05-30 | US | |
201361836088 P | 2013-06-17 | US | |
201361863365 P | 2013-08-07 | US | |
201361888454 P | 2013-10-08 | US | |
PCT/US2013/0679 | 2013-11-01 | WO | |
201461991414 P | 2014-05-09 | US |
(72) |
STERN, Howard, M., US
KUTOK, Jeffery, L., US
|
(73) |
Infinity Pharmaceuticals, Inc.,
780 Memorial Drive, Cambridge, MA 02139,
US
|
(54) | TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS |
TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS |